Your browser doesn't support javascript.
loading
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies.
Radawski, Christine A; Hammad, Tarek A; Colilla, Susan; Coplan, Paul; Hornbuckle, Kenneth; Freeman, Emily; Smith, Meredith Y; Sobel, Rachel E; Bahri, Priya; Arias, Ariel E; Bennett, Dimitri.
Afiliação
  • Radawski CA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
  • Hammad TA; Sanofi Genzyme, Global Pharmacovigilance, Cambridge, Massachusetts, USA.
  • Colilla S; Teva Pharmaceuticals, RWE & Epidemiology, Global Health Economics and Outcomes Research, West Chester, Pennsylvania, USA.
  • Coplan P; Johnson & Johnson, Epidemiology, New Brunswick, New Jersey, USA.
  • Hornbuckle K; Perelman School of Medicine, Adjunct, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Freeman E; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
  • Smith MY; Lundbeck Pharmaceuticals LLC, Global R&D, Patient Insights, Deerfield, Illinois, USA.
  • Sobel RE; Amgen, Inc., Global Patient Safety & Pediatrics, Thousand Oaks, California, USA.
  • Bahri P; Department of Regulatory and Quality Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, USA.
  • Arias AE; United Biosource Corporation (UBC)/Senior Consulting Group, Epidemiology, Blue Bell, Pennsylvania, USA.
  • Bennett D; European Medicine Agency (EMA), Quality and Safety of Medicines, Pharmacovigilance, Amsterdam, Netherlands.
Pharmacoepidemiol Drug Saf ; 29(12): 1532-1539, 2020 12.
Article em En | MEDLINE | ID: mdl-33146901

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article